135 related articles for article (PubMed ID: 32503562)
1. Tumor characteristics and treatment outcomes of older patients with breast cancer in Jordan.
Abdel-Razeq H; Abdel Rahman F; Almasri H; Abdulelah H; Abunasser M; Salam M; Taqash A
BMC Womens Health; 2020 Jun; 20(1):118. PubMed ID: 32503562
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer in young women from a low risk population in Nepal.
Thapa B; Singh Y; Sayami P; Shrestha UK; Sapkota R; Sayami G
Asian Pac J Cancer Prev; 2013; 14(9):5095-9. PubMed ID: 24175782
[TBL] [Abstract][Full Text] [Related]
6. Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts.
Wang J; Wang J; Li Q; Zhang P; Yuan P; Ma F; Luo Y; Cai R; Fan Y; Chen S; Li Q; Xu B
Oncotarget; 2017 Jul; 8(27):44851-44859. PubMed ID: 28206957
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis.
Arkoob K; Al-Nsour M; Al-Nemry O; Al-Hajawi B
East Mediterr Health J; 2010 Oct; 16(10):1032-8. PubMed ID: 21222418
[TBL] [Abstract][Full Text] [Related]
8. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
Cadoo KA; Morris PG; Cowell EP; Patil S; Hudis CA; McArthur HL
Clin Breast Cancer; 2016 Dec; 16(6):487-493. PubMed ID: 27622751
[TBL] [Abstract][Full Text] [Related]
11. Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.
Ho AY; Gupta G; King TA; Perez CA; Patil SM; Rogers KH; Wen YH; Brogi E; Morrow M; Hudis CA; Traina T; McCormick B; Powell SN; Robson ME
Cancer; 2012 Oct; 118(20):4944-52. PubMed ID: 22392492
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
13. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Gao JJ; Cheng J; Bloomquist E; Sanchez J; Wedam SB; Singh H; Amiri-Kordestani L; Ibrahim A; Sridhara R; Goldberg KB; Theoret MR; Kluetz PG; Blumenthal GM; Pazdur R; Beaver JA; Prowell TM
Lancet Oncol; 2020 Feb; 21(2):250-260. PubMed ID: 31859246
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Characteristics And Treatment Outcomes Of Breast Cancer Among Adolescents And Young Adults In A Developing Country.
Abdel-Razeq H; Almasri H; Abdel Rahman F; Abdulelah H; Abu Nasser M; Salam M; Al-Dairi A; Natour O; Rimawi D
Cancer Manag Res; 2019; 11():9891-9897. PubMed ID: 31819626
[TBL] [Abstract][Full Text] [Related]
15. Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute.
van der Leij F; van Werkhoven E; Bosma S; Linn SC; Rutgers EJ; van de Vijver MJ; Bartelink H; Elkhuizen PHM; Scholten A
Breast; 2016 Dec; 30():19-25. PubMed ID: 27587341
[TBL] [Abstract][Full Text] [Related]
16. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
17. Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study.
Anwar SL; Raharjo CA; Herviastuti R; Dwianingsih EK; Setyoheriyanto D; Avanti WS; Choridah L; Harahap WA; Darwito ; Aryandono T; Wulaningsih W
BMC Womens Health; 2019 Feb; 19(1):28. PubMed ID: 30728000
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis.
Jueckstock J; Kasch F; Jaeger B; Schramm A; Janni W; Scholz C
Arch Gynecol Obstet; 2015 Nov; 292(5):1101-7. PubMed ID: 25935195
[TBL] [Abstract][Full Text] [Related]
19. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
20. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
